Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) 69% HIGHER; Endo Pharma and Indevus today announced that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100% of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash (which is a 45% premium to Indevus Pharmaceuticals today), and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones. The transaction has been approved by the boards of directors of both companies.
TXCO Resources (Nasdaq: TXCO) 47% HIGHER; commodity-related stocks are surging today. The ...
StreetInsider.com Morning Movers:
Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) 70% HIGHER; Endo Pharma (Nasdaq: ENDP) and Indevus today announced that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100% of the outstanding shares of Indevus for approximately $370 million, or $4.50 per Indevus share, in cash (which is a 45% premium to Indevus Pharmaceuticals today), and up to an additional approximately $267 million, or $3.00 per Indevus share, in cash payable in the future upon achievement of certain regulatory and sales milestones. The transaction has been approved by the boards of directors of both companies.
Super Micro Computer, Inc. (NASDAQ: SMCI) 19% LOWER; now anticipates that it will report revenue for its second quarter of fiscal 2009 in the range of $127 to $129 million. This compares to the company’s previous guidance range of $140 to $150 million. The consensus is $143.5 ...
UPGRADES:
Oppenheimer upgrades Apple (Nasdaq: AAPL) from Perform to Outperform with a $135 price target.
Merriman Curhan upgrades Google (Nasdaq: GOOG) from Sell to Neutral.
Wachovia upgrades YRC Worldwide Inc. (Nasdaq: YRCW) to Market Perform, recent pessimism seems overblown ...
